This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2024-2026.
Company Filing History:
Years Active: 2024-2026
Title: Maria Johansson – Innovative Mind in Pharmaceutical Research
Introduction
Maria Johansson is a talented inventor based in Gothenburg, Sweden, known for her significant contributions in the field of pharmaceuticals. With one patent to her name, she has demonstrated her expertise and commitment to advancing medical science.
Latest Patents
Maria holds a patent for N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)-quinoline-4-carboxamides. This invention encompasses compounds that include pharmaceutically acceptable salts, designed to address Prolyl endopeptidase fibroblast activation protein (FAP)-mediated conditions. The patent outlines pharmaceutical compositions utilizing these compounds and salts, as well as kits and methods for manufacturing them.
Career Highlights
Currently, Maria works at AstraZeneca AB, a leading global biopharmaceutical company. Her involvement in groundbreaking research demonstrates her dedication to improving healthcare outcomes through innovative pharmaceutical solutions.
Collaborations
Maria collaborates with esteemed colleagues, including Jonas Brånalt and Anneli Nordqvist. Together, they contribute to the dynamic research environment at AstraZeneca, working towards the development of vital therapeutic interventions.
Conclusion
Maria Johansson exemplifies the innovative spirit in the pharmaceutical industry. Her patent and collaborative efforts reflect her commitment to addressing critical health challenges, emphasizing the important role inventors play in transforming healthcare through their inventions.